Case Report

Graves' Disease Associated with Cerebrovascular Disease and Antiphospholipid Antibody Syndrome

Table 1

Biological characteristic of the patient.

PatientNormal range

FT432.099–19 ng/l
TSH<0.0050.5–4.5 m UI/l
Anti-TSH receptor antibodies12<2 UI/ml
Antithyroglobulin antibodies194<50 UI/l
Antithyroperoxydase antibodies1534<50 UI/l
Anticardiolipin antibodies (IgM)41– <12 UI/l
β2GP-I antibodies (IgG)42– <10 UI /l

FT4: free thyroxin; TSH: Thyroid-stimulating hormone; β2GP-I: anti-β2-Glycoprotien-I.
t control, three months after.